Sutro Biopharma, Inc. is a clinical-stage company based in South San Francisco, California, dedicated to the discovery and development of precisely designed cancer therapeutics. With a focus on transforming the future of oncology, Sutro utilizes its fit-for-purpose technology, including cell-free XpressCF, to provide broader patient benefit and an improved patient experience.
Driven by innovative research and development, Sutro has developed six product candidates and is actively working independently and in collaboration with partners to develop novel cancer therapies, such as antibody-drug conjugates, bispecific antibodies, and cytokine derivatives targeting immuno-oncology pathways. Committed to diversity, equity, inclusion, and belonging, Sutro has partnered with California Life Sciences Association (CLSA) to create a more diverse industry and spark solutions for a better, healthier world.
Generated from the website